Characterization of a stem cell population in lung cancer cell line Glc-82

Thoracic Cancer

Volumn 3, Issue 1, 2012, Pages 8-18

  Long, Hao ^a   Zhang, Shulin ^a   Liu, Chunqi ^a   Shi, Jianlin ^a   Tao, Liyang ^b   Situ, Dongrong ^a   Ma, Guowei ^a   Zheng, Yan ^a   Fu, Liwu ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

ABCG2; EGFR; Multiple drug resistance; Side population

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CARBOPLATIN; CD133 ANTIGEN; CISPLATIN; DOCETAXEL; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; LAPATINIB; NAVELBINE; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CARCINOGENICITY; CELL CLONE; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTER; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE POPULATION CELL; STEM CELL;

EID: 84861356208     PISSN: 17597706     EISSN: 17597714     Source Type: Journal    
DOI: 10.1111/j.1759-7714.2011.00089.x     Document Type: Article

References (31)

1. Parkin DM, Bray F, Ferlay J etal. Global cancer statistics, 2002. CA Cancer J Clin 2005; 55: 74-108.
2. Jemal A, Siegel R, Ward E etal. Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66.
3. Bruce WR, Van Der Gaag H. A quantitative assay for the number of murine lymphoma cells capable of proliferation in vivo. Nature 2007; 199: 79-80.
4. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997; 3: 730-7.
5. Smalley M, Ashworth A. Stem cells and breast cancer: a field in transit. Nat Rev Cancer 2003; 3: 832-44.
6. Inoue A, Takahashi H, Harada H etal. Cancer stem-like cells of glioblastoma characteristically express MMP-13 and display highly invasive activity. Int J Oncol 2010; 37: 1121-31.
7. Bunting KD. ABC transporters as phenotypic markers and functional regulators of stem cells. Stem Cells 2002; 20: 11-20.
8. Yano S, Ito Y, Fujimoto M, Hamazaki TS etal. Characterization and localization of side population cells in mouse skin. Stem Cells 2005; 23: 834-41.
9. Salcido CD, Larochelle A, Taylor BJ etal. Molecular characterisation of side population cells with cancer stem cell-like characteristics in small-cell lung cancer. Br J Cancer 2010; 102: 1636-44.
10. Goodell MA, Brose K, Paradis G etal. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183: 1797-806.
11. Hirschmann-Jax C, Foster AE, Wulf GG etal. A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci U S A 2004; 101: 14228-33.
12. Kondo T, Setoguchi T, Taga T. Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci U S A 2004; 101: 781-6.
13. Patrawala L, Calhoun T, Schneider-Broussard R etal. Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic. Cancer Res 2005; 65: 6207-19.
14. Haraguchi N, Utsunomiya T, Inoue H etal. Characterization of a side population of cancer cells from human gastrointestinal system. Stem Cells 2006; 24: 506-13.
15. Ho MM, Ng AV, Lam S etal. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67: 4827-33.
16. Goodell MA, Rosenzweig M, Kim H etal. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997; 3: 1337-45.
17. Chen LM, Wu XP, Ruan JW etal. Screening novel, potent multidrug-resistant modulators from imidazole derivatives. Oncol Res 2004; 14: 355-62.
18. Shi Z, Liang YJ, Chen ZS etal. Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo. Cancer Biol Ther 2006; 5: 39-47.
19. Sung JM, Cho HJ, Yi H etal. Characterization of a stem cell population in lung cancer A549 cells. Biochem Biophys Res Commun 2008; 371: 163-7.
20. Zheng X, Shen G, Yang X etal. Most C6 cells are cancer stem cells: evidence from clonal and population analyses. Cancer Res 2007; 67: 3691-7.
21. Juliano RL, Ling V. A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 1976; 455: 152-62.
22. Scharenberg CW, Harkey MA, Torok-Storb B. The ABCG2 transporter is an efficient Hoechst 33342 efflux pump and is preferentially expressed by immature human hematopoietic progenitors. Blood 2002; 99: 507-12.
23. Jordan CT, Guzman ML, Noble M. Cancer stem cells. N Engl J Med 2006; 355: 1253-61.
24. Singh SK, Clarke ID, Terasaki M etal. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003; 63: 5821-28.
25. Patrawala L, Calhoun T, Schneider-Broussard R etal. Highly purified CD44+ prostate cancer cells from xenograft human tumors are enriched in tumorigenic and metastatic progenitor cells. Oncogene 2006; 25: 1696-708.
26. Ricci-Vitiani L, Lombardi DG, Pilozzi E etal. Identification and expansion of human colon-cancer-initiating cells. Nature 2006; 455: 111-5.
27. Kim K, Park BH, Ihm H etal. Expression of stem cell marker CD133 in fetal and adult human kidneys and pauci-immune crescentic glomerulonephritis. Histol Histopathol 2011; 26: 223-32.
28. Sun Y, Kong W, Falk A etal. CD133 (Prominin) negative human neural stem cells are clonogenic and tripotent. PLoS ONE 2009; 4: e5498.
29. Eramo A, Lotti F, Sette G etal. Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 2008; 15: 504-14.
30. Meng X, Li M, Wang X etal. Both CD133+ and CD133- subpopulations of A549 and H446 cells contain cancer-initiating cells. Cancer Sci 2009; 100: 1040-6.
31. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT etal. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A 2006; 103: 11154-9.